Language

Chinese English

Home page

Dr. Zhang Dan Appointed Chief Scientist of PUMCH Innovation Harbor

Mar 18,2026

On February 2, 2026, the Inaugural Ceremony of the PUMC Innovation Hub at the Chinese Academy of Medical Sciences and Peking Union Medical College was held. The event was attended by nearly 200 guests, including diplomatic envoys accredited to China, representatives from the Ministry of Science and Technology, the National Health Commission, and relevant departments of the Beijing Municipal Government, leaders of the CPC Dongcheng District Committee and the Dongcheng District People’s Government, university leaders, academicians and expert representatives, heads of various institutes and research centers, as well as representatives from medical institutions, universities, industry associations, central and municipally owned enterprises, and partner organizations.

Set for July 22–24: The Inaugural Global Conference on Innovative Drugs of Major Countries (CPIC) is Positioned as the “Clover”

Mar 15,2026

Over the past decade, China’s innovative pharmaceutical industry has risen rapidly and become deeply integrated into the global pharmaceutical landscape, emerging as a top priority for multinational pharmaceutical companies in their pipeline strategies. In both quantity and quality, China’s innovative drugs are fully commensurate with the country’s status as a major power. Moreover, the thriving biopharmaceutical sector has, for the first time, been officially designated by the state as an “emerging pillar industry.”

In Vivo CAR-T: “Saturation-Driven Innovation” After One Year

Mar 14,2026

The blind box is about to be opened

Banking capital is pouring into innovative drugs.

Mar 13,2026

How to Make the Best Use of Bank Financing?

A major pharmaceutical nation will inevitably become a leading force in new drug development.

Mar 08,2026

The National Strategic Status of the Biopharmaceutical Industry Is Undergoing a Historic Upgrade!

< 1...11 12 13 14 > proceed page